Mereo BioPharma Group Plc (MREO)
0.329
+0.01
(+2.81%)
USD |
NASDAQ |
Apr 14, 16:00
0.3297
0.00 (0.00%)
After-Hours: 20:00
Mereo BioPharma Group Total Assets (Quarterly) : 45.92M for Dec. 31, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Biodexa Pharmaceuticals Plc | -- |
| NuCana Plc | 40.13M |
| Bicycle Therapeutics Plc | 717.60M |
| Autolus Therapeutics Plc | 589.07M |
| DBV Technologies SA | 233.72M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 5.001M |
| Shareholders Equity (Quarterly) | 40.92M |
| Debt to Equity Ratio | 0.0049 |
| Current Ratio | 10.46 |
| Net Debt Paydown Yield | 1.96% |